LEBWOHL DAVID (EVP, Chief Medical Officer) sold 8.9% of their position (11.90K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $109.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/7/2026ACC: 0001193125-26-006283
Officer· EVP, Chief Medical Officer
Since Apr 2020
-11.90K
Net shares
Net seller
$109.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.90K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.90K
Price / share
$9.21
Trade value
$109.63K
% of position
8.9%
1/5/2026
133.15K→121.25K
Total
Net shares
−11.90K
Net value
-$109.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | S · Sale | −11.90K | $9.21 | $109.63K | 8.9% | 133.15K | 121.25K |
| Total | −11.90K | -$109.63K | ||||||
Derivative Transactions0
No derivative transactions reported